Objective To analyze the clinical application of Extracorporeal Cardiopulmonary Resuscita-tion(ECPR)in patients with refractory cardiac arrest in the emergency department and to investigate the factors affecting survival and neurological outcomes.Methods A retrospective analysis was conducted on the clinical data of 61 patients who underwent Extracorporeal Membrane Oxygenation(ECMO)for cardiopulmonary resuscitation at the emergency department from January 2021 to March 2024.The hospital discharge survival rate,favorable neuro-logical outcome rate,and incidence of complications were summarized.Factors affecting survival and neurological outcomes were also analyzed.Results In a study of 61 patients,the ECMO weaning success rate was 55.7%,the hospital discharge survival rate was 29.5%,the favorable neurological prognosis rate was 21.3%,and the incidence of complications was 47.5%.The proportion of initial cardiac rhythm being shockable was significantly higher in the survival group compared to the mortality group.The ECMO establishment time,low-flow time,and pre-ECMO blood lactate levels were all significantly lower in the survival group than in the mortality group.The pre-ECMO blood pH level was higher in the survival group.The ECMO maintenance time and ICU stay were significantly longer in the survival group than in the mortality group,with all P-values being less than 0.05,indicating statistically significant differences.Patients with an initial shockable cardiac rhythm and low-flow time≤60 minutes had a better favorable neurological prognosis rate.Conclusions Extracorporeal cardiopulmonary resuscitation can provide effective life support for patients with refractory cardiac arrest.Patients with an initial shockable rhythm,lower blood lactate levels and higher pH levels before ECMO support,and shorter low-flow time have a better prognosis.

Objective To analyze the clinical application of Extracorporeal Cardiopulmonary Resuscita-tion(ECPR)in patients with refractory cardiac arrest in the emergency department and to investigate the factors affecting survival and neurological outcomes.Methods A retrospective analysis was conducted on the clinical data of 61 patients who underwent Extracorporeal Membrane Oxygenation(ECMO)for cardiopulmonary resuscitation at the emergency department from January 2021 to March 2024.The hospital discharge survival rate,favorable neuro-logical outcome rate,and incidence of complications were summarized.Factors affecting survival and neurological outcomes were also analyzed.Results In a study of 61 patients,the ECMO weaning success rate was 55.7%,the hospital discharge survival rate was 29.5%,the favorable neurological prognosis rate was 21.3%,and the incidence of complications was 47.5%.The proportion of initial cardiac rhythm being shockable was significantly higher in the survival group compared to the mortality group.The ECMO establishment time,low-flow time,and pre-ECMO blood lactate levels were all significantly lower in the survival group than in the mortality group.The pre-ECMO blood pH level was higher in the survival group.The ECMO maintenance time and ICU stay were significantly longer in the survival group than in the mortality group,with all P-values being less than 0.05,indicating statistically significant differences.Patients with an initial shockable cardiac rhythm and low-flow time≤60 minutes had a better favorable neurological prognosis rate.Conclusions Extracorporeal cardiopulmonary resuscitation can provide effective life support for patients with refractory cardiac arrest.Patients with an initial shockable rhythm,lower blood lactate levels and higher pH levels before ECMO support,and shorter low-flow time have a better prognosis.

OBJECTIVE: To investigate the effect of circulating exosomes (EXO) on T cell function in patients with sepsis. METHODS: Plasma EXO were obtained by ultracentrifugation from 10 patients with sepsis admitted to the emergency intensive care unit of Guangdong Provincial People's Hospital Affiliated to Southern Medical University. Transmission electron microscopy observation, nanoparticle tracking analysis (NTA), and Western blotting were used to detect EXO markers to identify their characteristics. Furthermore, peripheral blood mononuclear cells (PBMC) were isolated from the peripheral blood of 5 healthy volunteers, primary T cells were sorted by magnetic beads and expanded in vitro. After 24 hours of intervention with different doses (0, 1, 2.5, 5, 10 mg/L) of circulating EXO in patients with sepsis, T-cell activity was assessed using a cell counting kit-8 (CCK-8). The expression of T cell activation indicators CD69 and CD25 were observed using flow cytometry. Additional evaluations were performed on immunosuppressive indicators including the expression of programmed cell death 1 (PD-1) in CD4⁺ T cells and the proportion of regulatory T cell (Treg). RESULTS: The identification results confirmed that the successful isolation of EXO from the plasma of sepsis patients. The expression level of circulating EXO in sepsis patients was higher than that in healthy control group (mg/L: 48.78±5.14 vs. 22.18±2.25, P < 0.01). After 24 hours of intervention with 5 mg/L of plasma EXO from sepsis patients, T cells activity began to show suppression [(85.84±0.56)% vs. (100.00±0.00)%, P < 0.05]. As the dosage increased, after 24 hours of intervention with 10 mg/L of EXO, T cells activity was significantly suppressed [(72.44±2.36)% vs. (100.00±0.00)%, P < 0.01]. Compared with the healthy control group, after T cells intervention with plasma EXO from sepsis patients, the expression of early activation marker CD69 was significantly reduced [(52.87±1.29)% vs. (67.13±3.56)%, P < 0.05]. Meanwhile, there was an upregulation of PD-1 expression in T cells [(57.73±3.06)% vs. (32.07±0.22)%, P < 0.01] and an increase in the proportion of Treg [(54.67±1.19)% vs. (24.60±3.51)%, P < 0.01]. However, the expression of the late activation marker CD25 remained stable [(84.77±3.44)% vs. (85.93±2.32)%, P > 0.05]. CONCLUSIONS Circulating EXO in sepsis patients induce T cell dysfunction, which may be a novel mechanism lead to immunosuppression in sepsis.
Humans ; Leukocytes, Mononuclear ; Exosomes/metabolism* ; Programmed Cell Death 1 Receptor/metabolism* ; T-Lymphocytes, Regulatory/metabolism* ; Sepsis/metabolism*